Telomere length as a risk marker for cardiovascular disease: the next big thing?

References

• Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat. Rep.52(9), 1–85 (2003).
   Google Scholar
• American Heart Association. Heart disease and stroke statistics – 2007 update. A report from the American Heart Association Statistics Committee and Stroke Subcomittee. Circulation115, E69–E171 (2007).
   PubMed Web of Science ®Google Scholar
• Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists? Int. J. Epidemiol.31, 1117–1122 (2002).
   PubMedGoogle Scholar
• McPherson R. Chromosome 9p21 and coronary artery disease. N. Engl. J. Med.362, 1736–1737 (2010).
   PubMedGoogle Scholar
• Folsom AR, Chambless LE, Ballantyne CM et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the Atherosclerosis Risk in Communities study. Arch. Intern. Med.166, 1368–1373 (2006).
   PubMed Web of Science ®Google Scholar
• Wang TJ, Gona P, Larson MG et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med.355, 2631–2639 (2006).
   PubMed Web of Science ®Google Scholar
• Mainous AG 3rd, Everett CJ, Player MS, King DE, Diaz VA. Importance of a patient’s personal health history on assessments of future risk of coronary heart disease. J. Am. Board Fam. Med.21, 408–413 (2008).
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Hoeg JM, D’Agostino RB et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N. Engl. J. Med.337, 516–522 (1997).
   PubMed Web of Science ®Google Scholar
• Ben-Shlomo Y, Smith GD, Shipley MJ, Marmot MG. What determines mortality risk in male former cigarette smokers? Am. J. Public Health84, 1235–1242 (1994).
   PubMedGoogle Scholar
• Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur. Heart J.21, 1621–1626 (2000).
   PubMedGoogle Scholar
• Janssens AC, van Duijn CM. Genome-based prediction of common diseases: methodological considerations for future research. Genome Med.1(2), 20 (2009).
   PubMed Web of Science ®Google Scholar
• Samani NJ, Tmaszewski M, Schunkert H. The personal genome – the future of personalised medicine? Lancet375, 1497–1498 (2010).
   PubMedGoogle Scholar
• Bielinski SJ, Pankow JS, Folsom AR, North KE, Boerwinkle E. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia51, 968–970 (2008).
   PubMedGoogle Scholar
• Morrison AC, Bare LA, Chambless LE et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities study. Am. J. Epidemiol.166, 28–35 (2007).
   PubMed Web of Science ®Google Scholar
• Paynter NP, Chasman DI, Pare G et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA303, 631–637 (2010).
   PubMed Web of Science ®Google Scholar
• Podgoreanu MV, White WD, Morris RW et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation114(Suppl. I), I275–I281 (2006).
   Google Scholar
• Samani NJ, Schunkert H. Chromosome 9p21 and cardiovascular disease: the story unfolds. Circ. Cardiovasc. Genet.1, 81–84 (2008).
   PubMedGoogle Scholar
• Andreassi MG. Metabolic syndrome, diabetes and atherosclerosis: influence of gene–environment interaction. Mutat. Res.667, 35–43 (2009).
   PubMed Web of Science ®Google Scholar
• Stephens JW, Bain SC, Humphries SE. Gene–environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis200, 229–238 (2008).
   PubMed Web of Science ®Google Scholar
• Tsai CT, Hwang JJ, Lai LP, Wang YC, Lin JL, Chiang FT. Interaction of gender, hypertension, and the angiotensinogen gene haplotypes on the risk of coronary artery disease in a large angiographic cohort. Atherosclerosis203, 249–256 (2009).
   PubMedGoogle Scholar
• Mainous AG 3rd, Codd V, Diaz VA et al. Leukocyte telomere length and coronary artery calcification. Atherosclerosis210, 262–267 (2010).
   PubMed Web of Science ®Google Scholar
• Diaz VA, Mainous AG 3rd, Everett CJ, Schoepf UJ, Codd V, Samani NJ. Effect of healthy lifestyle behaviors on the association between leukocyte telomere length and coronary artery calcium. Am. J. Cardiol.106(5), 659–663 (2010).
   PubMedGoogle Scholar
• Samani NJ, van der Harst P. Biological ageing and cardiovascular disease. Heart94, 537–539 (2008).
   PubMed Web of Science ®Google Scholar
• Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet358, 472–473 (2001).
   PubMed Web of Science ®Google Scholar
• Von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med.5, 197–203 (2005).
   PubMed Web of Science ®Google Scholar
• Njajou OT, Cawthon RM, Damcott CM et al. Telomere length is paternally inherited and is associated with parental lifespan. Proc. Natl Acad. Sci. USA104, 12135–12139 (2007).
   PubMed Web of Science ®Google Scholar
• Nawrot TS, Staessen JA, Gardner JP, Aviv A. Telomere length and possible link to X chromosome. Lancet363, 507–510 (2004).
   PubMed Web of Science ®Google Scholar
• Nordfjall K, Larefalk A, Lindgren P, Holmberg D, Roos G. Telomere length and heredity: indications of paternal inheritance. Proc. Natl Acad. Sci. USA102, 16374–16378 (2005).
   PubMed Web of Science ®Google Scholar
• Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in Type 2 diabetes. Diabetes Care29, 283–289 (2006).
   PubMed Web of Science ®Google Scholar
• Opresko PL, Fan J, Danzy S, Wilson DM 3rd, Bohr VA. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2. Nucleic Acids Res.33, 1230–1239 (2005).
   PubMed Web of Science ®Google Scholar
• Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the Heart and Soul study. PLoS ONE5(1), e8612 (2010).
   PubMedGoogle Scholar
• Puterman E, Lin J, Blackburn E et al. The power of exercise: buffering the effect of chronic stress on telomere length. PLoS ONE5(5), e10837 (2010).
   PubMed Web of Science ®Google Scholar
• Brouilette SW, Moore JS, McMahon AD et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case–control study. Lancet369, 107–114 (2007).
   PubMed Web of Science ®Google Scholar